BioLineRx Ltd. (BLRX) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-28 | 6-K | — | SEC |
| 2026-08-18 | 6-K | — | SEC |
| 2026-07-08 | 6-K | — | SEC |
| 2026-05-27 | 6-K | — | SEC |
| 2026-05-22 | 6-K | — | SEC |
| 2026-05-19 | 6-K | — | SEC |
| 2026-04-28 | 6-K | — | SEC |
| 2026-03-26 | 6-K | — | SEC |
| 2026-03-23 | 6-K | — | SEC |
| 2026-02-23 | 6-K | — | SEC |
| 2025-11-24 | 6-K | — | SEC |
| 2025-11-17 | 6-K | — | SEC |
| 2025-09-29 | 6-K | — | SEC |
| 2025-08-14 | 6-K | — | SEC |
| 2025-06-30 | 6-K | — | SEC |
| 2025-05-30 | 6-K | — | SEC |
| 2025-05-27 | 6-K | — | SEC |
| 2025-05-23 | 6-K | — | SEC |
| 2025-03-31 | 6-K | — | SEC |
| 2025-01-21 | 6-K | — | SEC |
| 2025-01-17 | 6-K | — | SEC |
| 2025-01-07 | 6-K | — | SEC |
| 2025-01-06 | 6-K | — | SEC |
| 2024-11-25 | 6-K | — | SEC |
| 2024-11-21 | 6-K | — | SEC |
| 2024-11-12 | 6-K | — | SEC |
| 2024-11-05 | 6-K | — | SEC |
| 2024-10-16 | 6-K | — | SEC |
| 2024-10-01 | 6-K | — | SEC |
| 2024-08-19 | 6-K | — | SEC |
| 2024-08-15 | 6-K | — | SEC |
| 2024-06-18 | 6-K | — | SEC |
| 2024-05-30 | 6-K | — | SEC |
| 2024-05-28 | 6-K | — | SEC |
| 2024-05-24 | 6-K | — | SEC |
| 2024-05-17 | 6-K | — | SEC |
| 2024-05-06 | 6-K | — | SEC |
| 2024-04-17 | 6-K | — | SEC |
| 2024-04-10 | 6-K | — | SEC |
| 2024-04-01 | 6-K | — | SEC |
| 2024-03-26 | 6-K | — | SEC |
| 2024-03-04 | 6-K | — | SEC |
| 2024-02-28 | 6-K | — | SEC |
| 2024-02-16 | 6-K | — | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.